Cargando…

Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type

BACKGROUND: HIV-1 Gag proteins are essential for virion assembly and viral replication in newly infected cells. Gag proteins are also strong determinants of viral infectivity; immune escape mutations in the Gag capsid (CA) protein can markedly reduce viral fitness, and interactions of CA with host p...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuoka, Saori, Dam, Elisabeth, Lecossier, Denise, Clavel, François, Hance, Allan J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653016/
https://www.ncbi.nlm.nih.gov/pubmed/19254360
http://dx.doi.org/10.1186/1742-4690-6-21
_version_ 1782165257410576384
author Matsuoka, Saori
Dam, Elisabeth
Lecossier, Denise
Clavel, François
Hance, Allan J
author_facet Matsuoka, Saori
Dam, Elisabeth
Lecossier, Denise
Clavel, François
Hance, Allan J
author_sort Matsuoka, Saori
collection PubMed
description BACKGROUND: HIV-1 Gag proteins are essential for virion assembly and viral replication in newly infected cells. Gag proteins are also strong determinants of viral infectivity; immune escape mutations in the Gag capsid (CA) protein can markedly reduce viral fitness, and interactions of CA with host proteins such as cyclophilin A (CypA) and TRIM5α can have important effects on viral infectivity. Little information, however, is available concerning the extent that different primary Gag proteins affect HIV-1 replication in different cell types, or the impact on viral replication of differences in the expression by target cells of proteins that interact with CA. To address these questions, we compared the infectivity of recombinant HIV-1 viruses expressing Gag-protease sequences from primary isolates in different target cells in the presence or absence of agents that disrupt cyclophilin A – CA interactions and correlated these results with the viral genotype and the expression of cyclophilin A and TRIM5α by the target cells. RESULTS: Viral infectivity was governed by the nature of the Gag proteins in a target cell-specific fashion. The treatment of target cells with agents that disrupt CypA-CA interactions often produced biphasic dose-response curves in which viral infectivity first increased and subsequently decreased as a function of the dose used. The extent that treatment of target cells with high-dose CypA inhibitors impaired viral infectivity was dependent on several factors, including the viral genotype, the nature of the target cell, and the extent that treatment with low-dose CypA inhibitors increased viral infectivity. Neither the presence of polymorphisms in the CA CypA-binding loop, the level of expression of CypA, or the level of TRIM5α expression could, alone, explain the differences in the shape of the dose-response curves observed or the extent that high-dose CypA inhibitors reduced viral infectivity. CONCLUSION: Multiple interactions between host-cell factors and Gag can strongly affect HIV-1 infectivity, and these vary according to target cell type and the origin of the Gag sequence. Two of the cellular activities involved appear to be modulated in opposite directions by CypA-CA interactions, and Gag sequences determine the intrinsic sensitivity of a given virus to each of these cellular activities.
format Text
id pubmed-2653016
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26530162009-03-10 Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type Matsuoka, Saori Dam, Elisabeth Lecossier, Denise Clavel, François Hance, Allan J Retrovirology Research BACKGROUND: HIV-1 Gag proteins are essential for virion assembly and viral replication in newly infected cells. Gag proteins are also strong determinants of viral infectivity; immune escape mutations in the Gag capsid (CA) protein can markedly reduce viral fitness, and interactions of CA with host proteins such as cyclophilin A (CypA) and TRIM5α can have important effects on viral infectivity. Little information, however, is available concerning the extent that different primary Gag proteins affect HIV-1 replication in different cell types, or the impact on viral replication of differences in the expression by target cells of proteins that interact with CA. To address these questions, we compared the infectivity of recombinant HIV-1 viruses expressing Gag-protease sequences from primary isolates in different target cells in the presence or absence of agents that disrupt cyclophilin A – CA interactions and correlated these results with the viral genotype and the expression of cyclophilin A and TRIM5α by the target cells. RESULTS: Viral infectivity was governed by the nature of the Gag proteins in a target cell-specific fashion. The treatment of target cells with agents that disrupt CypA-CA interactions often produced biphasic dose-response curves in which viral infectivity first increased and subsequently decreased as a function of the dose used. The extent that treatment of target cells with high-dose CypA inhibitors impaired viral infectivity was dependent on several factors, including the viral genotype, the nature of the target cell, and the extent that treatment with low-dose CypA inhibitors increased viral infectivity. Neither the presence of polymorphisms in the CA CypA-binding loop, the level of expression of CypA, or the level of TRIM5α expression could, alone, explain the differences in the shape of the dose-response curves observed or the extent that high-dose CypA inhibitors reduced viral infectivity. CONCLUSION: Multiple interactions between host-cell factors and Gag can strongly affect HIV-1 infectivity, and these vary according to target cell type and the origin of the Gag sequence. Two of the cellular activities involved appear to be modulated in opposite directions by CypA-CA interactions, and Gag sequences determine the intrinsic sensitivity of a given virus to each of these cellular activities. BioMed Central 2009-03-02 /pmc/articles/PMC2653016/ /pubmed/19254360 http://dx.doi.org/10.1186/1742-4690-6-21 Text en Copyright © 2009 Matsuoka et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Matsuoka, Saori
Dam, Elisabeth
Lecossier, Denise
Clavel, François
Hance, Allan J
Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type
title Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type
title_full Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type
title_fullStr Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type
title_full_unstemmed Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type
title_short Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type
title_sort modulation of hiv-1 infectivity and cyclophilin a-dependence by gag sequence and target cell type
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653016/
https://www.ncbi.nlm.nih.gov/pubmed/19254360
http://dx.doi.org/10.1186/1742-4690-6-21
work_keys_str_mv AT matsuokasaori modulationofhiv1infectivityandcyclophilinadependencebygagsequenceandtargetcelltype
AT damelisabeth modulationofhiv1infectivityandcyclophilinadependencebygagsequenceandtargetcelltype
AT lecossierdenise modulationofhiv1infectivityandcyclophilinadependencebygagsequenceandtargetcelltype
AT clavelfrancois modulationofhiv1infectivityandcyclophilinadependencebygagsequenceandtargetcelltype
AT hanceallanj modulationofhiv1infectivityandcyclophilinadependencebygagsequenceandtargetcelltype